The spin-out from Queen's University Belfast secured the cash injection from NetScientific and Qubis.

ProAxsis, a life sciences firm spun out from Queen’s University’s School of Pharmacy in August 2013, has secured its first major investment courtesy of NetScientific and Qubis. The amount, while undisclosed, will help the company create up to eight jobs over the next three years.

ProAxsis has developed a range of medical diagnostic test kits to enable routine monitoring of patients with chronic respiratory conditions such as cystic fibrosis, either in a hospital or at home. The company previously won…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.



Not sure if you have a subscription?